UBS Group
CAPR icon

UBS Group’s Capricor Therapeutics CAPR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$5.46M Buy
549,427
+156,084
+40% +$1.55M ﹤0.01% 2988
2025
Q1
$3.73M Buy
393,343
+270,525
+220% +$2.57M ﹤0.01% 3194
2024
Q4
$1.69M Buy
122,818
+109,700
+836% +$1.51M ﹤0.01% 3854
2024
Q3
$200K Buy
13,118
+4,431
+51% +$67.4K ﹤0.01% 4701
2024
Q2
$41.4K Buy
8,687
+7,187
+479% +$34.3K ﹤0.01% 5690
2024
Q1
$10.2K Buy
+1,500
New +$10.2K ﹤0.01% 6071
2023
Q2
Sell
-4,439
Closed -$18.7K 7857
2023
Q1
$18.7K Buy
+4,439
New +$18.7K ﹤0.01% 6042
2022
Q3
Sell
-29,352
Closed -$102K 9235
2022
Q2
$102K Buy
29,352
+22,462
+326% +$78.1K ﹤0.01% 4426
2022
Q1
$23K Buy
6,890
+3,142
+84% +$10.5K ﹤0.01% 6241
2021
Q4
$11K Buy
+3,748
New +$11K ﹤0.01% 7538
2021
Q3
Sell
-1,922
Closed -$10K 8379
2021
Q2
$10K Buy
1,922
+1,547
+413% +$8.05K ﹤0.01% 6925
2021
Q1
$2K Sell
375
-4,701
-93% -$25.1K ﹤0.01% 7557
2020
Q4
$17K Buy
5,076
+3,176
+167% +$10.6K ﹤0.01% 6034
2020
Q3
$10K Buy
1,900
+900
+90% +$4.74K ﹤0.01% 5961
2020
Q2
$5K Sell
1,000
-439
-31% -$2.2K ﹤0.01% 6501
2020
Q1
$2K Sell
1,439
-3,974
-73% -$5.52K ﹤0.01% 6673
2019
Q4
$7K Buy
5,413
+5,159
+2,031% +$6.67K ﹤0.01% 6360
2019
Q3
$1K Buy
+254
New +$1K ﹤0.01% 6844
2019
Q2
Sell
-33,702
Closed -$16K 6968
2019
Q1
$16K Buy
33,702
+19,767
+142% +$9.38K ﹤0.01% 5642
2018
Q4
$6K Buy
13,935
+13,221
+1,852% +$5.69K ﹤0.01% 6538
2018
Q3
$1K Sell
714
-550
-44% -$770 ﹤0.01% 6887
2018
Q2
$2K Buy
1,264
+864
+216% +$1.37K ﹤0.01% 6783
2018
Q1
$1K Sell
400
-3,979
-91% -$9.95K ﹤0.01% 6723
2017
Q4
$7K Buy
+4,379
New +$7K ﹤0.01% 6241
2017
Q2
Sell
-2,581
Closed -$9K 6695
2017
Q1
$9K Buy
2,581
+2,324
+904% +$8.1K ﹤0.01% 5738
2016
Q4
$1K Buy
+257
New +$1K ﹤0.01% 6605
2016
Q3
Sell
-2,996
Closed -$12K 6698
2016
Q2
$12K Buy
+2,996
New +$12K ﹤0.01% 5779
2015
Q4
Sell
-2,782
Closed -$11K 6865
2015
Q3
$11K Buy
2,782
+1,309
+89% +$5.18K ﹤0.01% 5857
2015
Q2
$7K Sell
1,473
-527
-26% -$2.5K ﹤0.01% 6136
2015
Q1
$17K Buy
+2,000
New +$17K ﹤0.01% 5492